A method has been developed and validated using headspace GC-FID for the identification of 1-phenylpropene in urine. This compound is a pyrolytic product of methamphetamine that has been previously proposed as a marker for smoked methampbetamine. The instrumentation used is the same as employed for blood alcohol determination. The extraction-free procedure is rapid, simple, and quantitative using 2-phenylpropene as the internal standard. The method was validated for linearity over a range of 0.1-20 pg/mL with a limit of detection of 0.05 pg/mL, limit of quantification of 0.1 pg/mL, interday accuracy within 3.2 to -5.3%, intraday accuracy better than 7.5%, interday precision of 7.5 to 10.7%, intraday precision of 2 to 8.6%, and recovery above 80%. For the robustness determination in urine, the accuracy of four different sources of urine at the mid control level (1 pg/mL) ranged from 1.6 to 19% error. The % relative standard deviation of the different urine sources ranged from 3.1 to 11%. Urine samples from nine methamphetamine-positive cases investigated by the Office of lhe Chief Medical Examiner of West Virginia were included in the study. 1 -Phenylpropene was found in two methamphetamine-positive cases (0.25 and 0.44 pg/mL).
Introduction
Of the many classes of abused central nervous system drugs, amphetamines remain popular as recreational drugs (1, 2) . The 1950s showed the first major wave of amphetamine abuse. The second wave of amphetamine abuse was relatively stable until 1980. The introduction of methamphetamine hydrochloride known as "ice", "crystal", or "glass" as a smokable form of methamphetamine in the mid-1980s, resulted in a third wave of amphetamine abuse (3) . Smokable forms of methamphetamine are popular because of their ease of use and rapid onset of euphoric stimulatory central nervous system effects (4) . Identified pyrolytic products of smoked methamphetamine hydrochloride include amphetamine, phenylacetone, allylbenzene, dimethylamphetamine, and 1-phenylpropene (trans-l-phenylpropene) (5) (6) (7) (8) . A major pyrolytic pathway of smoked drugs is the thermal elimination of an alkyl amine to form an olefin. Elimination of methylamine from methamphetamine gives both cis-phenylpropene and trans-phenylpropene, although the more stable transisomer is the predominant product (5). 1-Phenylpropene is one of the major thermal degradation products of methamphetamine hydrochloride and is a good candidate for use as a potential indicator of methamphetamine abuse by smoking, but there is only one method reported in the literature on the quantification of this compound (9) . The aim of the present study is to develop a quick, simple, sensitive, and extraction-free headspace gas chromatography-flameionization (GC-FID) method for the quantification of 1-phenylpropene in urine.
Headspace GC-FID and GC-mass spectrometry (MS) are commonly employed methods in forensic laboratories for blood alcohol, gamma-hydroxybutyrate (GHB), and abused inhalants (10) (11) (12) (13) . Pyrolytic products of many drugs of abuse are volatile and could be analyzed simply by headspace GC-FID using a suitable internal standard. Instrumental requirements would be the same as for headspace methods employed for determination of blood alcohol concentrations and therefore, already available to the forensic toxicology community. 
Experimental

Equipment
Methamphetamine and amphetamine urine concentrations were measured using Agilent 6890 series GC system equipped with an Agilent 5973 Network El MS. An HP-5 capillary column (30 m x 0.25-mm i.d., 0.254Jm film thickness) was used for chromatographic analysis. The injector port temperature was held at 250~ The initial GC temperature was mainrained at 120~ for 1.5 min, then increased to 300~ at the rate of 12.5~
and held for 7 min. Helium carrier gas was held at 1 mL/min by using pressure control. Quantification of methamphetamine and amphetamine was accomplished using full scan ion monitoring.
The GC used for the 1-phenylpropene analysis was a PerkinElmer Clams 500, and the FID (PerkinElmer) used an Equity 5 capillary column (30 m x 0.25-mm i.d., 0.25-1Jm film thickness). A PerkinElmer headspace sampler (HS 40XL) was used to introduce the sample to the GC-FID, and the system was configured for a routine blood alcohol analysis. Conditions are summarized in Table I .
Case reports
To evaluate the analytical method, urine samples from nine postmortem methamphetamine positive cases obtained from the Office of the Chief Medical Examiner of West Virginia. Each was screened for the presence of 1-phenylpropene. Two cases summarized were found to be positive. Case 1. After spending the evening at home with his children, a 41-year-old male was found the next morning lying across a bed. Toxicological analysis revealed cocaine rnetabolites were present in blood obtained at autopsy along with methadone. Cocaine, methamphetamine, methadone, hydrocodone, and dihydrocodeine were found in the urine. The cause of death was the result of combined cocaine and methadone intoxication. Ischemic heart disease was found to be a contributory factor. The urine methamphetamine concentration was 2716 ng/mL and the urine amphetamine concentration was 146 ng/mL.
Case2. Decedent is a 23-year-old male with a past history of suicide threats. Three days prior to his death, the decedent had 
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Oven temp. 80~ Injector temp. 250~ Carrier gas helium (20 mL/min) been described as being on a "rampage", alcohol intoxicated and threatening people with a gun. One afternoon a muffled gunshot was heard to come from his residence. Subsequent investigation established the cause of his death to be a gunshot wound to the head and the manner to be suicide. Postmortem toxicology testing revealed the decedent had a blood alcohol concentration of 0.08% with carboxy-THC present in the blood at 68 ng/mL. Methamphetamine, hydrocodone, dihydrocodeine, and acetaminophen were found in the urine. Urine methamphetamine concentration was 606 ng/mL, and amphetamine concentration was 206 ng/mL.
Analysis of methamphetamine and amphetamine in urine
To a 1-mL urine sample, 2.5 mL of 100mM phosphate buffer (pH 6) and 5 lJL internal standard (methaqualone, 0.1 mg/mL) were added. The mixture was vortex mixed for 30 s and sonicated for 15 rain using an ultrasonic bath. The mixture was centrifuged for 15 min at 3000 rpm. After pretreating the Trace B SPE column (SPE Ware, San Pedro, CA) with 2 mL ethyl acetate, 2 mL methanol, and I mL deionized water, the supernatant from the mixture was transferred to the column, and the flow was maintained at a rate of 2-5 mL/min. The column was then washed with 2 mL deionized water, 1 mL of 100ram acetic acid, 1 mL methanol, and 1 mL ethyl acetate. The column was dried for 2 min at 25 psi, and the drugs were eluted using 2 mL ethyl acetate containing 2% ammonium hydroxide. The elution was carried out at 1-2 mL/min. The organic layer was evaporated to 50-100 IIL at room temperature. The reduced drug sample was mixed with 20 IJL heptafluorobutyric anhydride and allowed to stand at room temperature for 20 rain. The mixture was evaporated to approximately 20-50 IJL, and 500 tJL of hexane and 1 mL of ammonium hydroxide were added and vortex mixed for 30 s. Two microliters of hexane layer was injected onto the GC-MS.
Calibration curve for 1-phenylpropene
Using 22-mL headspace vials, the following concentrations of 1-phenylpropene (0.1, 0.25, 0.50, 1.0, 5.0, 10, and 20 l~g/mL) were prepared in 900 I~L of blank urine by adding 100 ~L of stock solutions of 1-phenylpropene (1.0, 2.5, 5.0, 10, 50, 100, and 200 tJg/mL in methanol). All samples were spiked with 100 1JL of 2-phenylpropene in methanol (50 I~g/mL) as the internal standard. The samples were mixed on a vortex mixer for 10 s.
Analytical procedure (samples)
The total analysis time starting from frozen urine samples was about 140 rain. A urine sample volume of 900 l~L collected from nine separate cases were placed in 22 mL headspace vials. One-hundred microliters of the internal standard [2-phenylpropene (50 tJg/mL)] was added to each sample. The total volume is brought up to 1.1 mL with methanol. Samples were mixed for 10 rain on a vortex mixer and the vials were capped. The GC run time for each sample was 10 rain.
The ratio of the area under the curve of 1-phenylpropene (RT 6.66 min) to the area under the curve of 2-phenylpropene (RT 5.23 min) provides a quantitative estimate of the amount of 1-phenylpropene in urine samples.
Blank urine was analyzed before each sample run to verify the absence of 1-phenylpropene.
Stability of methamphetamine HCl under headspace GC-FID conditions
To determine if 1-phenylpropene was artifactually formed, blank urine samples were spiked with methamphetamine at high concentration (500 IJg/mL). These samples were also analyzed as described.
Results and Discussion
Peaks of the individual compounds, 1-phenylpropene (RT 6.66 rain) and 2-phenylpropene (RT 5.23 rain), present in the urine samples were well-resolved (Figure 1 ). Acceptable linearity was obtained over the 0.1-20 lJg/mL range (r 2 = 0.9991). Based on the experimental procedure, the limit of detection (LOD) was found to be 0.05 t~g/mL, and the limit of quantification (LOQ) was 0.1 lJg/mL. Other parameters are summarized in Figure 2 and Table II . The interday accuracy derived from three standards curves ranged from -1.3% to 43 %. The precision of alI the standards for the three runs ranged from 5.4% to 20.2%. Accuracy and precision of the analytical method were determined by the peak-area ratios (1-phenylpropene area under the curve to internal standard area under the curve) of standards and replicate control samples into a weighted linear regression equation (1/x 2) and back calculating concentrations. Intraday accuracy and precision were determined from a single accuracy and precision experiment with triplicates at each level. Interday precision ranged from 7.5% to 10.7%. Interday accuracy ranged from 3.2% to -5.3%, Table III . Intraday accuracy ranged from 3.1% to 7.5%. Intraday precision ranged from 2% to 8.6% (Table IV) . Interday accuracy and precision were established by preparing three separate accuracy and precision experiments on three separate days and compiling the data.
Specificity was determined by evaluating four different sources of urine (two females and two males) to evaluate potential interference with 1-phenylpropene and 2-phenylpropene. Of the four urine sources tested, no significant baseline interference from urinary components was detected at the retention time of 1-phenylpropene and 2-phenylpropene. There was no interference at the retention times of interest when a control urine sample that had been spiked with cocaine (0.5 I~g/mL), methadone (0.5 tJg/mL), hydrocodone (0.5 l~g/mL), THC (0.05 lag/mL), and acetaminophen (1 l~g/mL).
Analyte recovery was measured in the presence of the urine matrix using a spiked recovery method. The recovery of 1-phenylpropene was determined by comparison to the known amount added. The mean absolute recoveries ranged from 75 to 80% of 1-phenylpropene, and the % relative standard deviation (RSD) was less than 11%. The internal standard (2-phenylpropene) mean absolute recovery was 82%, and the % RSD was 8%.
To evaluate method robustness, four different sources of urine (two females and two males) were spiked at the l pg/mL level in triplicate and compared against a standard curve using an independent urine source. The accuracy of the four sources of urine ranged from 1.6% to 18.9% error. The precision of the four different urine sources ranged from 3.1% to 11%, as shown in Table V . The headspace GC-FID validated method was used to tentatively identify and quantify 1-phenylpropene in nine positive cases of methamphetamine provided by Office of the Chief Medical Examiner of West Virginia. Out of nine urine sample tested by the validated method, two samples were found to be positive for 1-phenylpropene. This may suggests smoking as the route of methamphetamine administration by the decedents. The concentrations of 1-phenylpropene in the positive samples were 0.25 and 0.44 lJg/mL. The ratio of methamphetamine to I-phenylpropene was 109 in the first case and 14 in the second case. The ratio of amphetamine to 1-phenylpropene in the first case was 6, and it was 5 in the second case. The higher ratios of methamphetamine to 1-phenylpropene in both cases are consistent with the metabolism of methamphetamine to amphetamine. The ratios also suggest that when present, ]-phenylpropene will be at a leveI much lower than methamphetamine concentration. Case information indicating route of methamphetamine ingestion was not available to the Office of the Chief Medical Examiner. Additional cases with better indications of administration are needed. 
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1-Phenylpropene was not artifactually formed during the analysis of methamphetamine under the headspace conditions discussed here.
Conclusions
The headspace GC-FID method described here is a simple method for tentative identification and quantitation of 1-phenylpropene as a potential biomarker of smoked methamphetamine. The advantages of this method are speed, simplicity, and the ability to use existing equipment routinely employed for blood alcohol measurements.
